BLACK WEEKSViale −15 % · kompleti −10 % · ostalo −5 %s kodoBrezplačna dostava v Nemčiji od 200 €

Ta stran je bila prevedena samodejno in lahko vsebuje napake. Ste materni govorec? Veseli bomo vaših povratnih informacij in popravkov.Pošljite povratne informacije

The Peptide Desk The Peptide Desk
Torasemid, fotografija izdelka
Medication

Torasemid

Medication

  • Odprema iz Nemčije

Naročilo

Cena na kos - Brezplačna dostava v Nemčiji od 200 € med Black Weeks
  • DHL s sledenjem
  • Diskretna embalaža

4.6 od 5 na Trustpilotu73 ocen

Na prvi pogled

Torasemid v številkah

Ključni podatki iz našega leksikona. Povlecite točko po krivulji in poglejte, koliko po izračunu ostane po enem odmerku.

Celoten vnos v leksikonu

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~3.5 hours

Half-life ~3.5 hours
After 7 hours: 25 %
Hour 445 %Hour 725 %Hour 1111.3 %Hour 182.8 %

Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 3 to 4 hours, we calculate with the middle.

Half-life

about3to4hours

duration 6 to 8 hours

Class
Loop diureticNKCC2 inhibitor
Use
Oral1x daily in the morning
Sizes
10 mg1 size in the shop

Znanje

Vse o Torasemid

Podrobne informacije bodo kmalu na voljo.

Odmerjanje

Nalaganje podatkov o odmerjanju …

Več v leksikonu

FAQ

Pogosta vprašanja

Viri za vsak odgovor: vnos v leksikonu

Imate še vprašanje?

Pišite nam, naša ekipa vam bo pomagala.

Is torsemide approved?

Yes. ChEMBL lists torsemide with phase 4 as the highest phase and first approval in 1993. ClinicalTrials.gov lists 56 trials with torsemide, as of 26 October 2026.

What did TRANSFORM-HF show?

2,859 patients received torsemide or furosemide after a hospital stay for heart failure. 26.1 versus 26.2 percent died, without difference. Death or hospital stay within 12 months did not differ significantly either (47.3 versus 49.3 percent).

How does absorption differ from furosemide?

Torsemide has a bioavailability of about 80 percent in healthy people, furosemide 26 to 65 percent. In heart failure the peak level was reached after 1.1 instead of 2.4 hours. Absorption varied less.

Why did earlier trials see an advantage?

An open trial with 234 patients found fewer hospital stays for heart failure (17 versus 32 percent). The TORIC observation with 1,377 patients saw lower mortality (2.2 versus 4.5 percent) but was not randomised. The larger randomised trial did not confirm this.

What about potassium?

In TORIC 12.9 percent on torsemide had low potassium at the end, 17.9 percent on furosemide or other diuretics. The groups were not randomised.

Do liver and kidney matter?

Torsemide is mainly broken down in the liver, only about 20 percent appear unchanged in the urine. In liver disease clearance fell to about half. In kidney failure total clearance stayed largely the same according to the review.

Sorodno

Sorodni izdelki